CTRI/2019/11/022009
Recruiting
未知
A randomized controlled trial to compare the efficacy of coupled transcranial stimulation with decoupled transcranial stimulation and sham stimulation as motor enhancement therapy for upper extremity in chronic ischemic stroke cases
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: I633- Cerebral infarction due to thrombosis of cerebral arteries
- Sponsor
- JIPMER
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •a)Age between 18year and 70year
- •b)Cases diagnosed as stroke by MRI/CT scan as non\-recurrent chronic MCA ischemic stroke
- •c)Cases after six months of post stroke
- •d)Normal as per Montreal Cognitive Assessment
- •e)Brunnstrom 3\-5 stages of recovery
Exclusion Criteria
- •a)Any contraindications for rTMS/tDCS intervention.
- •b)Any other associated neuropsychiatric disorder
- •c)Underwent any prior non\-invasive brain stimulation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
To study different pain relief modalities in preterm neonates during heel-stickHealth Condition 1: P84- Other problems with newbornCTRI/2023/09/057787Bharati Vidyapeeth Deemed University Medical College, Pune
Not yet recruiting
Not Applicable
A study to compare the effectiveness of Pericapsular nerve group block versus erector spinae plane block for pain control after hip surgeryCTRI/2022/11/047702ady Hardinge Medical College
Not yet recruiting
Not Applicable
to study the efficacy of pirfenidone in systemic sclerosis related interstitial lung diseaseHealth Condition 1: null- systemic sclerosis with interstitial lung diseaseCTRI/2018/01/011449Post graduate institute of medical education and research
Completed
Not Applicable
Comparison of sodium excreting effect between furosemide and indapamide combination with furosemide and metolazone combination in congestive heart failure patientsCongestive Heart FailureSLCTR/2017/041Rehman Medical Institute
Recruiting
Phase 2
A study to compare two medicines for lung disease in scleroderma patients- Tofacitinib ascompared to Mycophenolate MofetilHealth Condition 1: M340- Progressive systemic sclerosisCTRI/2024/05/067540Post Graduate Institute of Medical Education and Research Chandigarh